Anthropic, the artificial intelligence safety company backed by billions in investment, has acquired stealth biotech AI startup Coefficient Bio in a deal valued at approximately $400 million, according to reports from The Information and journalist Eric Newcomer.
The acquisition, structured as a stock deal, marks a significant move by Anthropic into the life sciences and biotechnology space. Coefficient Bio had been operating in stealth mode, meaning the startup had kept much of its work and operations out of the public eye prior to the reported acquisition.
The deal signals a growing trend among major AI companies seeking to expand their technological footprints beyond core software and language model development into high-stakes scientific fields such as drug discovery and biomedical research. Biotechnology has increasingly become an area of intense interest for AI firms, as machine learning and advanced models have demonstrated significant potential in accelerating scientific breakthroughs.
Anthropic, founded in 2021 by former OpenAI researchers including Dario Amodei and Daniela Amodei, has positioned itself as a safety-focused AI company and is best known for its Claude family of AI assistants. The company has attracted substantial investment from major players including Google and Amazon, giving it the financial resources to pursue strategic acquisitions of this scale.
The reported $400 million price tag underscores the growing valuation of AI-driven biotech ventures, even those that have yet to emerge from stealth operations. Investors and industry observers have long anticipated that the convergence of artificial intelligence and biotechnology would create significant acquisition activity as larger players race to secure specialized talent and proprietary technology.
Neither Anthropic nor Coefficient Bio had issued official public statements confirming the deal at the time of reporting. Further details regarding the terms of the transaction and how Coefficient Bio's work will be integrated into Anthropic's broader operations have yet to be disclosed.
